Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors.

A series of novel triazole-containing berberine derivatives were synthesized via the azide-alkyne cycloaddition reaction. Their biological activity as inhibitors of both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) were evaluated. Among them, compound 16d, which featured a diisopropylamino substitution at the 4-position of triazole ring, was found to be a potent inhibitor of AChE, with IC(50) value of 0.044 μM. Compound 18d, which beares a butyl at the 4-position of the triazole ring, showed the highest potency of β-amyloid aggregation inhibition (77.9% at 20 μM). Molecular modeling studies indicated that the triazole moiety of berberine derivatives displayed a face-to-face π-π stacking interaction in a 'sandwich' form with the Trp84 (4.09 Å) and Phe330 (4.33 Å) in catalytic sites of AChE.

[1]  E. De Clercq,et al.  1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity. , 1994, Journal of medicinal chemistry.

[2]  F. Santoyo-González,et al.  1,3-dipolar cycloadditions as a tool for the preparation of multivalent structures. , 2000, Organic letters.

[3]  Yun Tang,et al.  Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation. , 2008, Journal of medicinal chemistry.

[4]  Joel Morris,et al.  Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. , 2000, Journal of medicinal chemistry.

[5]  P. Taylor,et al.  Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks. , 2002, Angewandte Chemie.

[6]  M. G. Finn,et al.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions. , 2001, Angewandte Chemie.

[7]  C. Guillou,et al.  Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts. , 2000, Bioorganic & medicinal chemistry letters.

[8]  V. Andrisano,et al.  Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation. , 2005, Journal of medicinal chemistry.

[9]  William Lindstrom,et al.  Inhibitors of HIV-1 protease by using in situ click chemistry. , 2006, Angewandte Chemie.

[10]  R. Nilakantan,et al.  6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity. , 2001, Journal of medicinal chemistry.

[11]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[12]  G. Denardo,et al.  Construction of di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloaddition. , 2007, Chemical communications.

[13]  F. Santoyo-González,et al.  Multivalent neoglycoconjugates by regiospecific cycloaddition of alkynes and azides using organic-soluble copper catalysts. , 2003, Organic letters.

[14]  Zoran Radić,et al.  Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Zoran Radić,et al.  In situ selection of lead compounds by click chemistry: target-guided optimization of acetylcholinesterase inhibitors. , 2005, Journal of the American Chemical Society.

[16]  Xingshu Li,et al.  Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. , 2010, Bioorganic & medicinal chemistry.

[17]  David W McClymont,et al.  Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush. , 2008, Journal of medicinal chemistry.

[18]  Kwok‐yin Wong,et al.  9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA. , 2007, Bioorganic & medicinal chemistry.

[19]  M. Ueki,et al.  Antibacterial activity and structure-activity relationships of berberine analogs , 1996 .

[20]  M. Recanatini,et al.  Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeutics. , 2004, Current pharmaceutical design.

[21]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[22]  Wei Wang,et al.  Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonists. , 2009, Bioorganic & medicinal chemistry letters.

[23]  C. Pérez,et al.  Tacrine–Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties , 2009, ChemMedChem.